- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/07 - Tetrapeptides
Patent holdings for IPC class A61K 38/07
Total number of patents in this class: 1830
10-year publication summary
|
154
|
149
|
175
|
136
|
190
|
148
|
127
|
130
|
114
|
79
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Stealth Biotherapeutics Inc. | 196 |
82 |
| Amgen Inc. | 4486 |
21 |
| The Regents of the University of California | 20924 |
20 |
| Cornell University | 3458 |
17 |
| Onyx Therapeutics, Inc. | 65 |
17 |
| S.i.s. Shulov Innovative Science Ltd. | 18 |
17 |
| Cornell Research Foundation, Inc. | 161 |
16 |
| SeaGen Inc | 533 |
16 |
| ISP Investments Inc. | 439 |
15 |
| CARA Therapeutics, Inc. | 37 |
14 |
| Mondobiotech Laboratories AG | 310 |
14 |
| Stealth Biotherapeutics Corp | 36 |
14 |
| Stealth Peptides International, Inc. | 31 |
14 |
| Centre National de La Recherche Scientifique | 11122 |
13 |
| Agency for Science, Technology and Research | 3782 |
13 |
| Biotempt B.V. | 29 |
13 |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | 56 |
13 |
| Northwestern University | 3577 |
12 |
| Cytogel Pharma, LLC | 22 |
12 |
| The Feinstein Institute for Medical Research | 248 |
12 |
| Other owners | 1465 |